HEADER THREONINE BIOSYNTHESIS 04-AUG-00 1E5X TITLE STRUCTURE OF THREONINE SYNTHASE FROM ARABIDOPSIS THALIANA COMPND MOL_ID: 1; COMPND 2 MOLECULE: THREONINE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 4.2.99.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARABIDOPSIS THALIANA; SOURCE 3 ORGANISM_COMMON: MOUSE-EAR CRESS; SOURCE 4 ORGANISM_TAXID: 3702; SOURCE 5 ORGANELLE: CHLOROPLAST; SOURCE 6 CELLULAR_LOCATION: CHLOROPLAST; SOURCE 7 PLASMID: PET23; SOURCE 8 GENE: NUCLEAR; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMIDE; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: PET23; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PET23 THRC_ARATH; SOURCE 15 EXPRESSION_SYSTEM_GENE: THRC_ARATH; SOURCE 16 OTHER_DETAILS: MATURE ENZYME IS WITHOUT TRANSIT PEPTIDE KEYWDS THREONINE BIOSYNTHESIS, PLP ENZYME, S-ADENOSYL-METHIONINE, KEYWDS 2 ALLOSTERY EXPDTA X-RAY DIFFRACTION AUTHOR K.THOMAZEAU,G.CURIEN,R.DUMAS,V.BIOU REVDAT 2 24-FEB-09 1E5X 1 VERSN REVDAT 1 02-AUG-01 1E5X 0 JRNL AUTH K.THOMAZEAU,G.CURIEN,R.DUMAS,V.BIOU JRNL TITL CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM JRNL TITL 2 ARABIDOPSIS THALIANA JRNL REF PROTEIN SCI. V. 10 638 2001 JRNL REFN ISSN 0961-8368 JRNL PMID 11344332 JRNL DOI 10.1110/PS.44301 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1255563.21 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 41066 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2036 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6521 REMARK 3 BIN R VALUE (WORKING SET) : 0.318 REMARK 3 BIN FREE R VALUE : 0.356 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 326 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6691 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 210 REMARK 3 SOLVENT ATOMS : 388 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.5 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.13 REMARK 3 B22 (A**2) : 6.85 REMARK 3 B33 (A**2) : -12.98 REMARK 3 B12 (A**2) : 15.46 REMARK 3 B13 (A**2) : 1.26 REMARK 3 B23 (A**2) : -0.94 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.3 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.9 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.87 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.99 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.73 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.97 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.67 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.334225 REMARK 3 BSOL : 43 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : 0.204 ; 50 REMARK 3 GROUP 1 B-FACTOR (A**2) : 46.00 ; 1 REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SME.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : SME.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE C-TERMINAL RESIDUE OF MONOMER B REMARK 3 WAS NOT SEEN IN THE DENSITY MAPS REMARK 4 REMARK 4 1E5X COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-AUG-00. REMARK 100 THE PDBE ID CODE IS EBI-5161. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978873 REMARK 200 MONOCHROMATOR : SI (111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 124846 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.18300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13 % PEG 6000, 1M LICL, REMARK 280 MES PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 GLY A 3 REMARK 465 ASN A 4 REMARK 465 ASN A 5 REMARK 465 ILE A 6 REMARK 465 LYS A 7 REMARK 465 ALA A 8 REMARK 465 PRO A 9 REMARK 465 ALA A 28 REMARK 465 ARG A 29 REMARK 465 ARG A 30 REMARK 465 ASN A 31 REMARK 465 ARG A 32 REMARK 465 SER A 33 REMARK 465 SER A 65 REMARK 465 ARG A 66 REMARK 465 SER A 67 REMARK 465 GLY A 68 REMARK 465 MSE A 347 REMARK 465 THR A 348 REMARK 465 ALA A 349 REMARK 465 SER A 350 REMARK 465 THR A 351 REMARK 465 THR A 352 REMARK 465 PHE A 353 REMARK 465 ALA A 354 REMARK 465 SER A 355 REMARK 465 ALA A 356 REMARK 465 ILE A 357 REMARK 465 GLN A 358 REMARK 465 ILE A 359 REMARK 465 GLY A 360 REMARK 465 ASP A 361 REMARK 465 PRO A 362 REMARK 465 ALA B 1 REMARK 465 ASP B 2 REMARK 465 GLY B 3 REMARK 465 ASN B 4 REMARK 465 ASN B 5 REMARK 465 ILE B 6 REMARK 465 LYS B 7 REMARK 465 ALA B 8 REMARK 465 PRO B 9 REMARK 465 ILE B 10 REMARK 465 GLU B 11 REMARK 465 THR B 12 REMARK 465 ALA B 13 REMARK 465 VAL B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 ALA B 28 REMARK 465 ARG B 29 REMARK 465 ARG B 30 REMARK 465 ASN B 31 REMARK 465 ARG B 32 REMARK 465 SER B 33 REMARK 465 ASN B 34 REMARK 465 ALA B 35 REMARK 465 TYR B 63 REMARK 465 ARG B 64 REMARK 465 SER B 65 REMARK 465 ARG B 66 REMARK 465 SER B 67 REMARK 465 GLY B 68 REMARK 465 MSE B 347 REMARK 465 THR B 348 REMARK 465 ALA B 349 REMARK 465 SER B 350 REMARK 465 THR B 351 REMARK 465 THR B 352 REMARK 465 PHE B 353 REMARK 465 ALA B 354 REMARK 465 SER B 355 REMARK 465 ALA B 356 REMARK 465 ILE B 357 REMARK 465 GLN B 358 REMARK 465 ILE B 359 REMARK 465 GLY B 360 REMARK 465 ASP B 361 REMARK 465 PRO B 362 REMARK 465 GLY B 480 REMARK 465 SER B 481 REMARK 465 ASN B 482 REMARK 465 THR B 483 REMARK 465 LEU B 484 REMARK 465 THR B 485 REMARK 465 SER B 486 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 21 - O HOH A 2008 2.20 REMARK 500 OE2 GLU B 21 - O HOH B 2003 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 387 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 LEU B 387 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 26 92.98 -65.52 REMARK 500 ALA A 35 -156.52 -78.54 REMARK 500 ASN A 47 79.27 46.54 REMARK 500 ALA A 48 -149.97 -137.59 REMARK 500 ILE A 61 -32.25 -133.08 REMARK 500 TYR A 63 -115.73 -117.81 REMARK 500 VAL A 114 -70.10 -113.52 REMARK 500 MSE A 180 24.49 -75.85 REMARK 500 LYS A 181 14.76 52.44 REMARK 500 PRO A 183 116.26 -34.89 REMARK 500 ASN A 217 2.06 -69.01 REMARK 500 THR A 239 -173.59 -170.75 REMARK 500 LEU A 263 41.14 -91.55 REMARK 500 TRP A 341 -5.97 71.29 REMARK 500 SER A 364 91.76 73.58 REMARK 500 PHE A 400 77.91 -151.60 REMARK 500 ASN B 47 78.99 44.00 REMARK 500 ALA B 48 -168.94 -129.35 REMARK 500 SER B 52 -161.07 -100.13 REMARK 500 THR B 53 138.71 -172.29 REMARK 500 MSE B 180 24.40 -75.83 REMARK 500 LYS B 181 17.20 51.83 REMARK 500 PRO B 183 115.25 -36.57 REMARK 500 ASN B 217 0.92 -69.39 REMARK 500 THR B 239 -174.48 -176.39 REMARK 500 ASN B 261 22.77 -78.88 REMARK 500 LEU B 263 39.44 -92.22 REMARK 500 TRP B 341 -6.27 73.12 REMARK 500 SER B 364 88.28 69.20 REMARK 500 PHE B 400 79.43 -150.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE NUMBERING IN THE PDB FILE CORRESPONDS TO THE REMARK 999 MATURE PROTEIN, THEREFORE THERE IS A 40 AMINOACID REMARK 999 DIFFERENCE WITH RESPECT TO THE DATA BASE SEQUENCE. DBREF 1E5X A 1 486 UNP Q39144 Q39144 40 525 DBREF 1E5X B 1 486 UNP Q39144 Q39144 40 525 SEQADV 1E5X MSO A 309 UNP Q39144 MET 348 MODIFIED RESIDUE SEQADV 1E5X MSO B 309 UNP Q39144 MET 348 MODIFIED RESIDUE SEQADV 1E5X MSE A 77 UNP Q39144 MET 116 MODIFIED RESIDUE SEQADV 1E5X MSE A 146 UNP Q39144 MET 185 MODIFIED RESIDUE SEQADV 1E5X MSE A 167 UNP Q39144 MET 206 MODIFIED RESIDUE SEQADV 1E5X MSE A 180 UNP Q39144 MET 219 MODIFIED RESIDUE SEQADV 1E5X MSE A 221 UNP Q39144 MET 260 MODIFIED RESIDUE SEQADV 1E5X MSE A 245 UNP Q39144 MET 284 MODIFIED RESIDUE SEQADV 1E5X MSE A 322 UNP Q39144 MET 361 MODIFIED RESIDUE SEQADV 1E5X MSE A 388 UNP Q39144 MET 427 MODIFIED RESIDUE SEQADV 1E5X MSE A 391 UNP Q39144 MET 430 MODIFIED RESIDUE SEQADV 1E5X MSE A 399 UNP Q39144 MET 438 MODIFIED RESIDUE SEQADV 1E5X MSE A 453 UNP Q39144 MET 492 MODIFIED RESIDUE SEQADV 1E5X MSE A 472 UNP Q39144 MET 511 MODIFIED RESIDUE SEQADV 1E5X MSE B 77 UNP Q39144 MET 116 MODIFIED RESIDUE SEQADV 1E5X MSE B 146 UNP Q39144 MET 185 MODIFIED RESIDUE SEQADV 1E5X MSE B 167 UNP Q39144 MET 206 MODIFIED RESIDUE SEQADV 1E5X MSE B 180 UNP Q39144 MET 219 MODIFIED RESIDUE SEQADV 1E5X MSE B 221 UNP Q39144 MET 260 MODIFIED RESIDUE SEQADV 1E5X MSE B 245 UNP Q39144 MET 284 MODIFIED RESIDUE SEQADV 1E5X MSE B 322 UNP Q39144 MET 361 MODIFIED RESIDUE SEQADV 1E5X MSE B 388 UNP Q39144 MET 427 MODIFIED RESIDUE SEQADV 1E5X MSE B 391 UNP Q39144 MET 430 MODIFIED RESIDUE SEQADV 1E5X MSE B 399 UNP Q39144 MET 438 MODIFIED RESIDUE SEQADV 1E5X MSE B 453 UNP Q39144 MET 492 MODIFIED RESIDUE SEQADV 1E5X MSE B 472 UNP Q39144 MET 511 MODIFIED RESIDUE SEQRES 1 A 486 ALA ASP GLY ASN ASN ILE LYS ALA PRO ILE GLU THR ALA SEQRES 2 A 486 VAL LYS PRO PRO HIS ARG THR GLU ASP ASN ILE ARG ASP SEQRES 3 A 486 GLU ALA ARG ARG ASN ARG SER ASN ALA VAL ASN PRO PHE SEQRES 4 A 486 SER ALA LYS TYR VAL PRO PHE ASN ALA ALA PRO GLY SER SEQRES 5 A 486 THR GLU SER TYR SER LEU ASP GLU ILE VAL TYR ARG SER SEQRES 6 A 486 ARG SER GLY GLY LEU LEU ASP VAL GLU HIS ASP MSE GLU SEQRES 7 A 486 ALA LEU LYS ARG PHE ASP GLY ALA TYR TRP ARG ASP LEU SEQRES 8 A 486 PHE ASP SER ARG VAL GLY LYS SER THR TRP PRO TYR GLY SEQRES 9 A 486 SER GLY VAL TRP SER LYS LYS GLU TRP VAL LEU PRO GLU SEQRES 10 A 486 ILE ASP ASP ASP ASP ILE VAL SER ALA PHE GLU GLY ASN SEQRES 11 A 486 SER ASN LEU PHE TRP ALA GLU ARG PHE GLY LYS GLN PHE SEQRES 12 A 486 LEU GLY MSE ASN ASP LEU TRP VAL LYS HIS CYS GLY ILE SEQRES 13 A 486 SER HIS THR GLY SER PHE LYS ASP LEU GLY MSE THR VAL SEQRES 14 A 486 LEU VAL SER GLN VAL ASN ARG LEU ARG LYS MSE LYS ARG SEQRES 15 A 486 PRO VAL VAL GLY VAL GLY CYS ALA SER THR GLY ASP THR SEQRES 16 A 486 SER ALA ALA LEU SER ALA TYR CYS ALA SER ALA GLY ILE SEQRES 17 A 486 PRO SER ILE VAL PHE LEU PRO ALA ASN LYS ILE SER MSE SEQRES 18 A 486 ALA GLN LEU VAL GLN PRO ILE ALA ASN GLY ALA PHE VAL SEQRES 19 A 486 LEU SER ILE ASP THR ASP PHE ASP GLY CYS MSE LYS LEU SEQRES 20 A 486 ILE ARG GLU ILE THR ALA GLU LEU PRO ILE TYR LEU ALA SEQRES 21 A 486 ASN SER LEU ASN SER LEU ARG LEU GLU GLY GLN LYS THR SEQRES 22 A 486 ALA ALA ILE GLU ILE LEU GLN GLN PHE ASP TRP GLN VAL SEQRES 23 A 486 PRO ASP TRP VAL ILE VAL PRO GLY GLY ASN LEU GLY ASN SEQRES 24 A 486 ILE TYR ALA PHE TYR LYS GLY PHE LYS MSO CYS GLN GLU SEQRES 25 A 486 LEU GLY LEU VAL ASP ARG ILE PRO ARG MSE VAL CYS ALA SEQRES 26 A 486 GLN ALA ALA ASN ALA ASN PRO LEU TYR LEU HIS TYR LYS SEQRES 27 A 486 SER GLY TRP LYS ASP PHE LYS PRO MSE THR ALA SER THR SEQRES 28 A 486 THR PHE ALA SER ALA ILE GLN ILE GLY ASP PRO VAL SER SEQRES 29 A 486 ILE ASP ARG ALA VAL TYR ALA LEU LYS LYS CYS ASN GLY SEQRES 30 A 486 ILE VAL GLU GLU ALA THR GLU GLU GLU LEU MSE ASP ALA SEQRES 31 A 486 MSE ALA GLN ALA ASP SER THR GLY MSE PHE ILE CYS PRO SEQRES 32 A 486 HIS THR GLY VAL ALA LEU THR ALA LEU PHE LYS LEU ARG SEQRES 33 A 486 ASN GLN GLY VAL ILE ALA PRO THR ASP ARG THR VAL VAL SEQRES 34 A 486 VAL SER THR ALA HIS GLY LEU LYS PHE THR GLN SER LYS SEQRES 35 A 486 ILE ASP TYR HIS SER ASN ALA ILE PRO ASP MSE ALA CYS SEQRES 36 A 486 ARG PHE SER ASN PRO PRO VAL ASP VAL LYS ALA ASP PHE SEQRES 37 A 486 GLY ALA VAL MSE ASP VAL LEU LYS SER TYR LEU GLY SER SEQRES 38 A 486 ASN THR LEU THR SER SEQRES 1 B 486 ALA ASP GLY ASN ASN ILE LYS ALA PRO ILE GLU THR ALA SEQRES 2 B 486 VAL LYS PRO PRO HIS ARG THR GLU ASP ASN ILE ARG ASP SEQRES 3 B 486 GLU ALA ARG ARG ASN ARG SER ASN ALA VAL ASN PRO PHE SEQRES 4 B 486 SER ALA LYS TYR VAL PRO PHE ASN ALA ALA PRO GLY SER SEQRES 5 B 486 THR GLU SER TYR SER LEU ASP GLU ILE VAL TYR ARG SER SEQRES 6 B 486 ARG SER GLY GLY LEU LEU ASP VAL GLU HIS ASP MSE GLU SEQRES 7 B 486 ALA LEU LYS ARG PHE ASP GLY ALA TYR TRP ARG ASP LEU SEQRES 8 B 486 PHE ASP SER ARG VAL GLY LYS SER THR TRP PRO TYR GLY SEQRES 9 B 486 SER GLY VAL TRP SER LYS LYS GLU TRP VAL LEU PRO GLU SEQRES 10 B 486 ILE ASP ASP ASP ASP ILE VAL SER ALA PHE GLU GLY ASN SEQRES 11 B 486 SER ASN LEU PHE TRP ALA GLU ARG PHE GLY LYS GLN PHE SEQRES 12 B 486 LEU GLY MSE ASN ASP LEU TRP VAL LYS HIS CYS GLY ILE SEQRES 13 B 486 SER HIS THR GLY SER PHE LYS ASP LEU GLY MSE THR VAL SEQRES 14 B 486 LEU VAL SER GLN VAL ASN ARG LEU ARG LYS MSE LYS ARG SEQRES 15 B 486 PRO VAL VAL GLY VAL GLY CYS ALA SER THR GLY ASP THR SEQRES 16 B 486 SER ALA ALA LEU SER ALA TYR CYS ALA SER ALA GLY ILE SEQRES 17 B 486 PRO SER ILE VAL PHE LEU PRO ALA ASN LYS ILE SER MSE SEQRES 18 B 486 ALA GLN LEU VAL GLN PRO ILE ALA ASN GLY ALA PHE VAL SEQRES 19 B 486 LEU SER ILE ASP THR ASP PHE ASP GLY CYS MSE LYS LEU SEQRES 20 B 486 ILE ARG GLU ILE THR ALA GLU LEU PRO ILE TYR LEU ALA SEQRES 21 B 486 ASN SER LEU ASN SER LEU ARG LEU GLU GLY GLN LYS THR SEQRES 22 B 486 ALA ALA ILE GLU ILE LEU GLN GLN PHE ASP TRP GLN VAL SEQRES 23 B 486 PRO ASP TRP VAL ILE VAL PRO GLY GLY ASN LEU GLY ASN SEQRES 24 B 486 ILE TYR ALA PHE TYR LYS GLY PHE LYS MSO CYS GLN GLU SEQRES 25 B 486 LEU GLY LEU VAL ASP ARG ILE PRO ARG MSE VAL CYS ALA SEQRES 26 B 486 GLN ALA ALA ASN ALA ASN PRO LEU TYR LEU HIS TYR LYS SEQRES 27 B 486 SER GLY TRP LYS ASP PHE LYS PRO MSE THR ALA SER THR SEQRES 28 B 486 THR PHE ALA SER ALA ILE GLN ILE GLY ASP PRO VAL SER SEQRES 29 B 486 ILE ASP ARG ALA VAL TYR ALA LEU LYS LYS CYS ASN GLY SEQRES 30 B 486 ILE VAL GLU GLU ALA THR GLU GLU GLU LEU MSE ASP ALA SEQRES 31 B 486 MSE ALA GLN ALA ASP SER THR GLY MSE PHE ILE CYS PRO SEQRES 32 B 486 HIS THR GLY VAL ALA LEU THR ALA LEU PHE LYS LEU ARG SEQRES 33 B 486 ASN GLN GLY VAL ILE ALA PRO THR ASP ARG THR VAL VAL SEQRES 34 B 486 VAL SER THR ALA HIS GLY LEU LYS PHE THR GLN SER LYS SEQRES 35 B 486 ILE ASP TYR HIS SER ASN ALA ILE PRO ASP MSE ALA CYS SEQRES 36 B 486 ARG PHE SER ASN PRO PRO VAL ASP VAL LYS ALA ASP PHE SEQRES 37 B 486 GLY ALA VAL MSE ASP VAL LEU LYS SER TYR LEU GLY SER SEQRES 38 B 486 ASN THR LEU THR SER MODRES 1E5X MSE A 77 MET SELENOMETHIONINE MODRES 1E5X MSE A 146 MET SELENOMETHIONINE MODRES 1E5X MSE A 167 MET SELENOMETHIONINE MODRES 1E5X MSE A 180 MET SELENOMETHIONINE MODRES 1E5X MSE A 221 MET SELENOMETHIONINE MODRES 1E5X MSE A 245 MET SELENOMETHIONINE MODRES 1E5X MSE A 322 MET SELENOMETHIONINE MODRES 1E5X MSE A 388 MET SELENOMETHIONINE MODRES 1E5X MSE A 391 MET SELENOMETHIONINE MODRES 1E5X MSE A 399 MET SELENOMETHIONINE MODRES 1E5X MSE A 453 MET SELENOMETHIONINE MODRES 1E5X MSE A 472 MET SELENOMETHIONINE MODRES 1E5X MSE B 77 MET SELENOMETHIONINE MODRES 1E5X MSE B 146 MET SELENOMETHIONINE MODRES 1E5X MSE B 167 MET SELENOMETHIONINE MODRES 1E5X MSE B 180 MET SELENOMETHIONINE MODRES 1E5X MSE B 221 MET SELENOMETHIONINE MODRES 1E5X MSE B 245 MET SELENOMETHIONINE MODRES 1E5X MSE B 322 MET SELENOMETHIONINE MODRES 1E5X MSE B 388 MET SELENOMETHIONINE MODRES 1E5X MSE B 391 MET SELENOMETHIONINE MODRES 1E5X MSE B 399 MET SELENOMETHIONINE MODRES 1E5X MSE B 453 MET SELENOMETHIONINE MODRES 1E5X MSE B 472 MET SELENOMETHIONINE MODRES 1E5X MSO A 309 MET METHIONINE SULFOXIDE MODRES 1E5X MSO B 309 MET METHIONINE SULFOXIDE HET MSE A 77 8 HET MSE A 146 8 HET MSE A 167 8 HET MSE A 180 8 HET MSE A 221 8 HET MSE A 245 8 HET MSO A 309 9 HET MSE A 322 8 HET MSE A 388 8 HET MSE A 391 8 HET MSE A 399 8 HET MSE A 453 8 HET MSE A 472 8 HET MSE B 77 8 HET MSE B 146 8 HET MSE B 167 8 HET MSE B 180 8 HET MSE B 221 8 HET MSE B 245 8 HET MSO B 309 9 HET MSE B 322 8 HET MSE B 388 8 HET MSE B 391 8 HET MSE B 399 8 HET MSE B 453 8 HET MSE B 472 8 HETNAM MSE SELENOMETHIONINE HETNAM MSO SELENOMETHIONINE SELENOXIDE FORMUL 1 MSE 24(C5 H11 N O2 SE) FORMUL 1 MSO 2(C5 H11 N O3 SE) FORMUL 3 HOH *388(H2 O1) HELIX 1 1 ARG A 19 ARG A 25 1 7 HELIX 2 2 ASP A 76 ARG A 82 1 7 HELIX 3 3 ASP A 84 SER A 94 1 11 HELIX 4 4 VAL A 107 LYS A 111 5 5 HELIX 5 5 LYS A 110 VAL A 114 5 5 HELIX 6 6 ASP A 119 ILE A 123 5 5 HELIX 7 7 ALA A 136 GLY A 145 1 10 HELIX 8 8 LYS A 163 MSE A 180 1 18 HELIX 9 9 GLY A 193 GLY A 207 1 15 HELIX 10 10 ASN A 217 ILE A 219 5 3 HELIX 11 11 SER A 220 VAL A 225 1 6 HELIX 12 12 LEU A 224 ASN A 230 1 7 HELIX 13 13 ASP A 240 LEU A 255 1 16 HELIX 14 14 LEU A 263 LYS A 272 1 10 HELIX 15 15 LYS A 272 PHE A 282 1 11 HELIX 16 16 LEU A 297 LYS A 308 1 12 HELIX 17 17 PRO A 332 SER A 339 1 8 HELIX 18 18 ILE A 365 CYS A 375 1 11 HELIX 19 19 THR A 383 THR A 397 1 15 HELIX 20 20 CYS A 402 GLN A 418 1 17 HELIX 21 21 HIS A 434 LYS A 437 5 4 HELIX 22 22 PHE A 438 SER A 447 1 10 HELIX 23 23 ASP A 467 LEU A 479 1 13 HELIX 24 24 ARG B 19 ASP B 26 1 8 HELIX 25 25 ASP B 76 LYS B 81 1 6 HELIX 26 26 ASP B 84 SER B 94 1 11 HELIX 27 27 VAL B 107 LYS B 111 5 5 HELIX 28 28 LYS B 110 VAL B 114 5 5 HELIX 29 29 ASP B 119 ILE B 123 5 5 HELIX 30 30 ALA B 136 GLY B 145 1 10 HELIX 31 31 LYS B 163 MSE B 180 1 18 HELIX 32 32 GLY B 193 GLY B 207 1 15 HELIX 33 33 ASN B 217 ILE B 219 5 3 HELIX 34 34 SER B 220 VAL B 225 1 6 HELIX 35 35 LEU B 224 ASN B 230 1 7 HELIX 36 36 ASP B 240 LEU B 255 1 16 HELIX 37 37 LEU B 263 LYS B 272 1 10 HELIX 38 38 LYS B 272 PHE B 282 1 11 HELIX 39 39 LEU B 297 LYS B 308 1 12 HELIX 40 40 PRO B 332 SER B 339 1 8 HELIX 41 41 ILE B 365 CYS B 375 1 11 HELIX 42 42 THR B 383 THR B 397 1 15 HELIX 43 43 CYS B 402 GLN B 418 1 17 HELIX 44 44 HIS B 434 LYS B 437 5 4 HELIX 45 45 PHE B 438 SER B 447 1 10 HELIX 46 46 ASP B 467 LEU B 479 1 13 SHEET 1 A 2 ALA A 41 PRO A 45 0 SHEET 2 A 2 LEU A 71 HIS A 75 -1 N GLU A 74 O LYS A 42 SHEET 1 B 4 LEU A 133 TRP A 135 0 SHEET 2 B 4 LEU A 149 HIS A 153 -1 N VAL A 151 O PHE A 134 SHEET 3 B 4 THR A 427 SER A 431 1 N THR A 427 O TRP A 150 SHEET 4 B 4 TRP A 289 VAL A 292 1 N TRP A 289 O VAL A 428 SHEET 1 C 4 ILE A 257 LEU A 259 0 SHEET 2 C 4 GLY A 186 CYS A 189 1 N GLY A 186 O TYR A 258 SHEET 3 C 4 SER A 210 PRO A 215 1 N ILE A 211 O VAL A 187 SHEET 4 C 4 PHE A 233 ILE A 237 1 N PHE A 233 O VAL A 212 SHEET 1 D 2 CYS A 324 ALA A 327 0 SHEET 2 D 2 VAL A 379 ALA A 382 1 N GLU A 380 O CYS A 324 SHEET 1 E 2 ALA B 41 PRO B 45 0 SHEET 2 E 2 LEU B 71 HIS B 75 -1 N GLU B 74 O LYS B 42 SHEET 1 F 4 LEU B 133 TRP B 135 0 SHEET 2 F 4 LEU B 149 HIS B 153 -1 N VAL B 151 O PHE B 134 SHEET 3 F 4 THR B 427 SER B 431 1 N THR B 427 O TRP B 150 SHEET 4 F 4 TRP B 289 VAL B 292 1 N TRP B 289 O VAL B 428 SHEET 1 G 4 ILE B 257 LEU B 259 0 SHEET 2 G 4 GLY B 186 CYS B 189 1 N GLY B 186 O TYR B 258 SHEET 3 G 4 SER B 210 PRO B 215 1 N ILE B 211 O VAL B 187 SHEET 4 G 4 PHE B 233 ILE B 237 1 N PHE B 233 O VAL B 212 SHEET 1 H 2 CYS B 324 ALA B 327 0 SHEET 2 H 2 VAL B 379 ALA B 382 1 N GLU B 380 O CYS B 324 LINK C ASP A 76 N MSE A 77 1555 1555 1.33 LINK C MSE A 77 N GLU A 78 1555 1555 1.33 LINK C GLY A 145 N MSE A 146 1555 1555 1.33 LINK C MSE A 146 N ASN A 147 1555 1555 1.33 LINK C GLY A 166 N MSE A 167 1555 1555 1.33 LINK C MSE A 167 N THR A 168 1555 1555 1.33 LINK C LYS A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N LYS A 181 1555 1555 1.33 LINK C SER A 220 N MSE A 221 1555 1555 1.33 LINK C MSE A 221 N ALA A 222 1555 1555 1.33 LINK C CYS A 244 N MSE A 245 1555 1555 1.33 LINK C MSE A 245 N LYS A 246 1555 1555 1.33 LINK C LYS A 308 N MSO A 309 1555 1555 1.33 LINK C MSO A 309 N CYS A 310 1555 1555 1.33 LINK C ARG A 321 N MSE A 322 1555 1555 1.33 LINK C MSE A 322 N VAL A 323 1555 1555 1.32 LINK C LEU A 387 N MSE A 388 1555 1555 1.33 LINK C MSE A 388 N ASP A 389 1555 1555 1.33 LINK C ALA A 390 N MSE A 391 1555 1555 1.33 LINK C MSE A 391 N ALA A 392 1555 1555 1.33 LINK C GLY A 398 N MSE A 399 1555 1555 1.33 LINK C MSE A 399 N PHE A 400 1555 1555 1.33 LINK C ASP A 452 N MSE A 453 1555 1555 1.33 LINK C MSE A 453 N ALA A 454 1555 1555 1.33 LINK C VAL A 471 N MSE A 472 1555 1555 1.33 LINK C MSE A 472 N ASP A 473 1555 1555 1.33 LINK C ASP B 76 N MSE B 77 1555 1555 1.33 LINK C MSE B 77 N GLU B 78 1555 1555 1.32 LINK C GLY B 145 N MSE B 146 1555 1555 1.33 LINK C MSE B 146 N ASN B 147 1555 1555 1.33 LINK C GLY B 166 N MSE B 167 1555 1555 1.33 LINK C MSE B 167 N THR B 168 1555 1555 1.33 LINK C LYS B 179 N MSE B 180 1555 1555 1.33 LINK C MSE B 180 N LYS B 181 1555 1555 1.33 LINK C SER B 220 N MSE B 221 1555 1555 1.33 LINK C MSE B 221 N ALA B 222 1555 1555 1.33 LINK C CYS B 244 N MSE B 245 1555 1555 1.33 LINK C MSE B 245 N LYS B 246 1555 1555 1.33 LINK C LYS B 308 N MSO B 309 1555 1555 1.33 LINK C MSO B 309 N CYS B 310 1555 1555 1.33 LINK C ARG B 321 N MSE B 322 1555 1555 1.33 LINK C MSE B 322 N VAL B 323 1555 1555 1.33 LINK C LEU B 387 N MSE B 388 1555 1555 1.33 LINK C MSE B 388 N ASP B 389 1555 1555 1.33 LINK C ALA B 390 N MSE B 391 1555 1555 1.33 LINK C MSE B 391 N ALA B 392 1555 1555 1.33 LINK C GLY B 398 N MSE B 399 1555 1555 1.33 LINK C MSE B 399 N PHE B 400 1555 1555 1.33 LINK C ASP B 452 N MSE B 453 1555 1555 1.33 LINK C MSE B 453 N ALA B 454 1555 1555 1.33 LINK C VAL B 471 N MSE B 472 1555 1555 1.33 LINK C MSE B 472 N ASP B 473 1555 1555 1.33 CISPEP 1 TRP A 101 PRO A 102 0 -0.26 CISPEP 2 TRP B 101 PRO B 102 0 -0.30 CRYST1 57.760 62.140 76.590 109.48 97.61 112.74 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017313 0.007256 0.005916 0.00000 SCALE2 0.000000 0.017449 0.008094 0.00000 SCALE3 0.000000 0.000000 0.014521 0.00000 MTRIX1 1 0.943150 -0.129620 0.306040 -6.20155 1 MTRIX2 1 -0.129040 -0.991390 -0.022230 2.77128 1 MTRIX3 1 0.306280 -0.018530 -0.951760 40.84748 1